Population
CV-1 cells transfected with plasmid DNA containing the gene for chloramphenicol acetyl transferase coupled…
Comparison
Antisense oligonucleotide analogues at 30 microM… vs "Normal" phosphodiester oligonucleotides
Design
Preclinical
Authors
Loading...
Modified analogues enhance preclinical potency; leaves open translation to human cardiovascular gene therapies.
Phosphorothioate and methylphosphonate antisense oligonucleotide analogues are more potent inhibitors of targeted gene expression than normal phosphodiester oligonucleotides in vitro.
Marcus-Sekura et al. (1987) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: